Showing results (221-230 of 326) with videos related to
Sort By:
Pageof 33
Neuro-Oncology|October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglioMartha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.The Lancet. Oncology|May 15, 2012
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialWolfgang Wick, Michael Platten, Christoph Meisner, et al.Neuro-Oncology|July 17, 2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialBenedikt Wiestler, David Capper, Volker Hovestadt, et al.Cell|April 14, 2023
Cancer neuroscience: State of the field, emerging directionsFrank Winkler, Humsa S Venkatesh, Moran Amit, et al.Neurology|September 27, 2013
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutationWolfgang Wick, Christoph Meisner, Bettina Hentschel, et al.Scientific Reports|January 25, 2017
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosisTobias V Lanz, Sarah K Williams, Aleksandar Stojic, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2018
Targeting Resistance against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor TrametinibAnne Berberich, Tobias Kessler, Carina M Thomé, et al.Nature Communications|May 7, 2026
Ferroptosis-armed dendritic cell vaccines for glioma immunotherapyMariia Saviuk, Victoria D Turubanova, Sara De Brée, et al.Acta Neuropathologica|September 16, 2023
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosisAnnika Hofmann, Nik Krajnc, Assunta Dal-Bianco, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune diseasePeggy P Ho, Paulo Fontoura, Michael Platten, et al.Pageof 33